Media
Check Out What’s New at Goldfinch
Press Releases
07.27.21
Goldfinch Bio Announces Upcoming Presentations at the 13th International Podocyte Conference
06.14.21
Goldfinch Bio to Present at the Raymond James Human Health Innovation Conference
05.13.21
Goldfinch Bio Initiates Phase 1 Clinical Trial of GFB-024, a Novel Precision Medicine Product Candidate for Patients with Severe Insulin Resistant Diabetic Nephropathy (DN)
04.20.21
Goldfinch Bio Expands Board of Directors with Appointments of Meryl Zausner, Hon. William “Mo” Cowan and Tyrell Rivers, Ph.D.
11.19.20